Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques
Pharmaceutics · 19.01.2025 · 17 (1) · 136
DOI: 10.3390/pharmaceutics17010136 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 19.01.2025. Verfasst von Shery Jacob und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University, Ajman 4184, United Arab Emirates. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 276 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gulf Medical University, Ajman, United Arab Emirates.
Abstract (Originalsprache)
Nanosuspensions (NS), with their submicron particle sizes and unique physicochemical properties, provide a versatile solution for enhancing the administration of medications that are not highly soluble in water or lipids. This review highlights recent advancements, future prospects, and challenges in NS-based drug delivery, particularly for oral, ocular, transdermal, pulmonary, and parenteral routes. The conversion of oral NS into powders, pellets, granules, tablets, and capsules, and their incorporation into film dosage forms to address stability concerns is thoroughly reviewed. This article summarizes key stabilizers, polymers, surfactants, and excipients used in NS formulations, along with ongoing clinical trials and recent patents. Furthermore, a comprehensive analysis of various methods for NS preparation is provided. This article also explores various in vitro and in vivo characterization techniques, as well as scale-down technologies and bottom-up methods for NS preparation. Selected examples of commercial NS drug products are discussed. Rapid advances in the field of NS could resolve issues related to permeability-limited absorption and hepatic first-pass metabolism, offering promise for medications based on proteins and peptides. The evolution of novel stabilizers is essential to overcome the current limitations in NS formulations, enhancing their stability, bioavailability, targeting ability, and safety profile, which ultimately accelerates their clinical application and commercialization.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University, Ajman 4184, United Arab Emirates.
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
- Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
- Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
ORCID-Profile: Shery Jacob, Fathima Sheik Kather, Sai H S Boddu, Mahesh Attimarad, Anroop B Nair
Förderung
- Gulf Medical University, Ajman, United Arab Emirates
Zitieren
APA
Jacob, S., Kather, F. S., Boddu, S. H. S., Attimarad, M., & Nair, A. B. (2025). Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques. Pharmaceutics, 17(1), 136. https://doi.org/10.3390/pharmaceutics17010136
Vancouver
Jacob S, Kather FS, Boddu SHS, Attimarad M, Nair AB. Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques. Pharmaceutics. 2025;17(1):136. doi:10.3390/pharmaceutics17010136
BibTeX
@article{Jacob2025,
author = {Jacob, Shery and Kather, Fathima Sheik and Boddu, Sai H S and Attimarad, Mahesh and Nair, Anroop B},
title = {Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {1},
pages = {136},
doi = {10.3390/pharmaceutics17010136}
}
EUVIMED